GlobeNewsWire
12 Jun 2026, 07:00 UTC · 3h ago
Evaxion receives Prix Galien UK Award for Best digital health solution
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
GlobeNewsWire
12 Jun 2026, 07:00 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Evaxion's AI-Immunology™ platform received the 2026 Prix Galien UK Award for Best digital health solution. — Industry awards provide external validation of technology efficacy, which can improve investor confidence and partnership prospects for clinical-stage biotech companies.
+0.30This is the second recognition from the Galien Prix Foundation for the company in less than one year. — Repeated recognition suggests a consistent pattern of technical superiority and validation across different regional juries.
+0.20Which stocks this story touches
The company received the Prix Galien UK Award for Best digital health solution, providing strong external validation for its AI-Immunology platform.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
47m ago
